Read Time:7 Second
Drug manufacturer Catalent said higher-than-expected costs and productivity issues at three plants would have a material adverse impact on fiscal third-quarter earnings.
Happy
0 %
Sad
0 %
Excited
0 %
Sleepy
0 %
Angry
0 %
Surprise
0 %
0
0
